Medical screening services provider ClearStar said it had seen a 'significant' uptick in revenue from the end of May following the impact on performance from the Covid-19 pandemic. The Covid-19 outbreak significantly impacted its business due to the impact on the labour market, but the company's performance had steadied following the reopening of all 50 states in the US. 'While we have not yet returned to our pre-COVID-19 revenue run rate, the increase in sales so far is extremely encouraging. As the US economic recovery progresses and our customers are able to resume more normal trading, we expect this growth in our activity to continue,' it added. At 9:22am: (LON:CLSU) Clearstar Inc. share price was +1p at 39p
Sign up to our
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine
Plus more useful investment content and occasional promotional offers.
UK 350 Risers and Fallers
Tweets not available.